After losing some value lately, a hammer chart pattern has been formed for Strive, Inc. (ASST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
MP Materials stock seems stuck. Should you buy or wait?
TJX Companies Inc (NYSE:TJX) reported stronger-than-expected first-quarter results on Wednesday, as a surge in customer traffic across all its retail banners lifted sales and profit above estimates. Net sales rose 9% year over year to $14.3 billion, topping the $14 billion consensus estimate,...
Tether International is deepening its position in Twenty One Capital (NYSE: $XXI) after acquiring SoftBank’s ...
LOW beats Q1 earnings and sales estimates as Pro momentum, spring demand and online sales growth drive comps amid a tough housing market.
The TJ Maxx parent posted first-quarter earnings of $1.19 per share and raised its full-year EPS outlook to $5.08–$5.15
Marvell Technology stock has more than doubled in 2026 so far, but it could still fly higher.
Based on the average brokerage recommendation (ABR), Snowflake (SNOW) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Applied Materials beat analyst estimates in its latest quarterly results following a historic bull run.
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
IBM (NYSE:IBM) has expanded its AI security portfolio, adding new AI-powered security services aimed at detecting and responding to AI-driven cyber threats. The company has entered a partnership with Anthropic to support Project Glasswing, which focuses on securing open-source software across critical infrastructure. These developments are intended to strengthen defenses against AI-enabled attacks and support shared vulnerability discovery and remediation across the wider security...
If you are wondering whether Broadcom's current share price still makes sense after its strong run, the next sections will walk through what the numbers say about value. The stock recently closed at US$411.07, with returns of 18.3% year to date and 78.9% over the past year, while the share price has slipped about 2% over the last week and is up 1.1% over the past month. Alongside these price moves, recent coverage has focused on Broadcom's role as a large semiconductor and infrastructure...
In recent days, Newmont reported strong first-quarter results, expanded its share repurchase authorization by US$6.00 billion, and advanced talks with Barrick about adding the Fourmile discovery to their existing Nevada Gold Mines joint venture, even as investors reacted to macroeconomic pressures on gold and higher expected operating costs. The tension between robust current performance and earnings expectations on one hand, and concerns over rising costs, lower future output, and gold...
Oklo may seem like a promising growth investment, but it comes with some significant risks and question marks.
This may be one of the biggest opportunities in big tech right now.
The Mediterranean fast-casual chain posted same-restaurant sales growth of 9.7%, lifted by a 6.8% rise in guest traffic
Wood just added Cerebras, the latest hot AI name, to two of her Ark Invest funds.
With markets choppy and growth names getting hammered into May, the sub-$20 corner of the market is suddenly worth a second look. Two of the most talked-about fintech and travel tech names have been beaten down well below their highs, but the underlying businesses keep posting numbers that argue the sell-off is overdone. For retail ... 2 High-Growth Stocks Under $20 That Make for Screaming Buys Right Now
The stock's reaction captures the market's growing skepticism that a "beat-and-affirm" quarter is enough to break Lowe's out of a sideways pattern.
Mega-cap AI stocks have done the heavy lifting for two years, but a quieter shift is underway. Some billionaire investors have started trimming positions in NVIDIA (NASDAQ:NVDA) after a 62.77% one-year run and a $5.38 trillion market cap, rotating dollars into smaller AI-exposed names where the upside curve is steeper. The hunt is on for ... Billionaires Are Dumping Nvidia and Buying This Unstoppable AI Stock Under $10 Hand Over Fist
Strategy Inc.'s latest Bitcoin acquisition and groundbreaking dividend signal could unlock significant new capital from income-focused institutional funds.
The booming global semiconductor market will be "tense" with tight supply for the foreseeable future, the head of chip-making machine giant ASML told Reuters, with demand from AI, satellites and robots outpacing what the industry can produce. In a rare interview on the sidelines of a tech event in Antwerp, ASML Chief Executive Christophe Fouquet said that there would likely be sporadic bottlenecks throughout the supply chain of the chip market which could hit $1.5 trillion by 2030. "Demand on AI is coming so strongly that we will be in a supply-limited market for quite a while," Fouquet said, citing plans like Elon Musk's huge proposed "TeraFab" AI plan and Starlink satellites as potentially driving a new leg of demand.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
At $223.15, Arm Holdings (NASDAQ:ARM) screens as attractive to accumulators, with research desks pointing to the $210 to $215 range on any pullback as a favored entry zone. The stock has rebounded sharply from a steep first-quarter drawdown, and the post-earnings story has fundamentally changed what Arm is selling to Wall Street. Arm designs the ... Arm Holdings Is Up 104% and Smart Money Is Waiting for One Specific Level to Buy More
Analog Devices Inc. (NASDAQ:ADI) reported fiscal second-quarter 2026 results that came in ahead of analyst expectations, with both earnings and revenue exceeding the upper end of the company’s own guidance range.
CVS is more than a dividend play.
AFRM shares are down 12.3% YTD, but active users, GMV and transactions are surging as inflation fears and rising debt keep pressure on the stock.
Regenxbio Inc (NASDAQ:RGNX) is one of the best gene therapy stocks to buy in 2026. On May 14, Regenxbio reported its Q1 2026 financial results and provided operational updates. The company exited the quarter with $150.5 million in cash. The management expects the cash balance to be enough to fund operations into early 2027. Regenxbio […]